# Newark Beth Israel Medical Center - Blood Bank – FDA Inspection, Oct 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/newark-beth-israel-medical-center-blood-bank/979cfab4-e792-4caf-8cba-bb9d65675f15
Source feed: FDA_Inspections

> FDA inspection 1220208 of Newark Beth Israel Medical Center - Blood Bank, October 13, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 606. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220208
- Company Name: Newark Beth Israel Medical Center - Blood Bank
- Inspection Date: 2023-10-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1314854 - 2026-04-22
- FDA Inspection 1168186 - 2022-04-26
- FDA Inspection 1061410 - 2018-07-26
- FDA Inspection 989086 - 2016-09-22
- FDA Inspection 887560 - 2014-07-15

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/amy-w-yan-mai/00551315-3a03-4327-ab3a-71de5c1577d4)

Company: https://www.keypedia.com/companies/newark-beth-israel-medical-center-blood-bank/52d58d3a-a59b-49c6-afca-d48b36706fb8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d